Latest stories on AMGN
Amgen Inc. stock underperforms Friday when compared to competitors
MarketWatch42 · neutralgeneral
Chip stocks lead Nasdaq's weekly gains; Amgen plunges after trial setback
Seeking Alpha58 · neutralgeneral
Amgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?
The Motley Fool53 · neutralanalyst
Positive Lung Cancer Data Lifts the Case for Amgen and AstraZeneca
Yahoo Finance73 · bullishproduct/pr
Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
The Motley Fool54 · neutralanalyst
Amgen Drops 10% on a Trial It Didn't Even Run
MarketBeat32 · bearishearnings
Why is Amgen stock sliding today?
Investing.com Markets48 · neutralgeneral
Amgen’s New Repatha Plaque Trial: What Investors Should Watch
TipRanks56 · neutralproduct/pr
Amgen vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo Top54 · neutralanalyst
Amgen vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?
The Motley Fool54 · neutralanalyst
Amgen: Buy The Novartis-Driven Selloff (Rating Upgrade)
Seeking Alpha67 · bullishanalyst
HSBC downgrades Amgen to Hold on fair value after re-rating
The Fly48 · neutralanalyst
HSBC downgrades Amgen stock rating to Hold on valuation
Investing.com Analyst Ratings46 · neutralanalyst
Amgen's Forward Multiple Looks Cheap Until You Price The Margins It Assumes
Yahoo Top42 · neutralanalyst
Amgen downgraded to Hold from Buy at HSBC
The Fly48 · neutralanalyst
Could AstraZeneca (AZN)’s Stronger Growth Make it a Better Bet than Amgen (AMGN)?
Yahoo Top56 · neutralanalyst
AMGEN TO PRESENT AT THE MORGAN STANLEY 24TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
PR Newswire55 · neutralgeneral
TEX Daily Recap: September 8, 2026
CNBC28 · bearishgeneral
Amgen and AstraZeneca report positive lung cancer trial results
Investing.com Markets73 · bullishproduct/pr
Amgen slides 10% amid olpasiran read-through concerns
Seeking Alpha32 · bearishgeneral
Amgen-AstraZeneca drug combo helps lung cancer patients live longer in late-stage study
Reuters73 · bullishproduct/pr
Amgen: Why Rivals' Cholesterol Drug Fail Is Bad News For The Pharma (Rating Downgrade)
Seeking Alpha38 · neutralproduct/pr
Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%
Yahoo Top28 · bearishgeneral
Amgen, Astra drug combo extends survival in late-stage trial for lung cancer
Seeking Alpha73 · bullishproduct/pr